Daniel L. Goodwin’s Sanofi SNY Stock Holding History

Daniel L. Goodwin’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,000	Closed	-$249K	–	92
2017 Q3	$249K	Sell	5,000 -1	-0%	-$48	0.11%	80
2017 Q2	$239K	Buy	+5,001	New	+$239K	0.11%	84

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Daniel L. Goodwin's SNY Position: Q4 2017 in Review

Daniel L. Goodwin sold out of Sanofi (SNY) in Q4 2017, closing a stake of 5,000 shares — an estimated $249K sold.

Daniel L. Goodwin first reported a position in SNY in Q2 2017 and held it in 2 quarters. The position peaked at $249K in Q3 2017. 504 funds tracked by Wall St. Rank hold SNY as of Q4 2017.

Daniel L. Goodwin reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
Daniel L. Goodwin sold 5,000 Sanofi shares in Q4 2017, an estimated $249K.
Daniel L. Goodwin first reported a position in Sanofi in Q2 2017 and held it in 2 quarters.
Daniel L. Goodwin's Sanofi position peaked at $249K in Q3 2017.
504 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.

Based on Daniel L. Goodwin's 13F filing for Q4 2017, filed 23 Jan 2018.